Finnish deep-tech company
CeLLife Technologies has closed a €4 million post-seed funding round with participation from 2C Ventures, Butterfly Ventures, the European Innovation Council (EIC), and existing investors, including Ventech.
Founded in Tampere,
CeLLife Technologies is building a battery quality and health intelligence platform for the global battery industry. Its patented Electrical Fingerprint (EFP™) technology captures battery measurement data in seconds and converts it into actionable diagnostics, traceability, and decision-support insights across the battery lifecycle.
The company’s chemistry-agnostic platform supports a wide range of battery technologies, including NMC, LFP, NCA, solid-state, and sodium-ion cells, and is designed for battery manufacturers, module and pack assemblers, recyclers, and energy storage operators.
CeLLife has already secured paying customers across three market segments and recently signed its first major commercial agreement with a leading European recycling company. The company was also named among the Top 10 winners of the European Startup Prize for Mobility in 2025.
“This funding enables us to accelerate the commercial rollout of CeLLife’s battery quality and health intelligence platform,” said
Dr. Roni Luhtala, Co-founder and CEO of CeLLife Technologies. “Battery manufacturers, recyclers, and energy storage operators all face the same challenge: they need faster, more reliable visibility into battery quality, condition, and performance. We are building the diagnostics and decision-support infrastructure needed across the full battery lifecycle.”
The funding will support CeLLife’s commercial expansion across Europe and North America, with a focus on battery recycling, quality control for battery modules and packs, and condition monitoring solutions for battery energy storage systems (BESS). The company is also positioning its platform to support growing demand for battery traceability and digital battery passports under upcoming EU Battery Regulation requirements.
“CeLLife's technology has the potential to disrupt battery diagnostics across the entire value chain, from manufacturing to inbound quality control and end-of-life recycling,” said
Hendrik Reimand, Founding Partner at 2C Ventures. “It combines a clear value proposition to customers and a disruptive commercial opportunity with a significant environmental benefit — exactly what we look for at 2C Ventures.”